Analystreport

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $67.00 to $50.00.

Atara Biotherapeutics, Inc.  (ATRA) 
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.atarabio.com/investor-relations